Key points are not available for this paper at this time.
Probiotics show promise as an adjunctive intervention for cognitive decline, but larger, long-term trials are needed to confirm their efficacy and clinical applicability in neurodegenerative diseases like AD.
Quansah et al. (Fri,) studied this question.